VarCov Co’s Calumet Specialty Products CLMT Stock Holding History

VarCov Co’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,979	Closed	-$1.08M	–	390
2026 Q1	$1.08M	Buy	+29,979	New	+$776K	0.4%	69

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VarCov Co's CLMT Position: Q2 2026 in Review

VarCov Co sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 29,979 shares — an estimated $1.08M sold.

VarCov Co first reported a position in CLMT in Q1 2026 and held it in 1 quarter. The position peaked at $1.08M in Q1 2026. 187 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

VarCov Co reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 29,979 Calumet Specialty Products shares in Q2 2026, an estimated $1.08M.
VarCov Co first reported a position in Calumet Specialty Products in Q1 2026 and held it in 1 quarter.
VarCov Co's Calumet Specialty Products position peaked at $1.08M in Q1 2026.
187 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.